Skip to content
Mid-day Mood | Market swings gains and losses, Fed chair speech eyed for cues

Mid-day Mood | Market swings gains and losses, Fed chair speech eyed for cues

Midcap stocks managed to outperform the frontline indices, with Nifty Midcap 50 trading 0.56 percent higher from the previous close

Read More

​ Midcap stocks managed to outperform the frontline indices, with Nifty Midcap 50 trading 0.56 percent higher from the previous close Midcap stocks managed to outperform the frontline indices, with Nifty Midcap 50 trading 0.56 percent higher from the previous close  Moneycontrol Latest News Read More  

Midcap stocks managed to outperform the frontline indices, with Nifty Midcap 50 trading 0.56 percent higher from the previous close

Mid-day Mood | Market swings between gains and losses, Fed chair speech eyed for cues

Mid-day Mood | Market swings between gains and losses, Fed chair speech eyed for cues

Midcap stocks managed to outperform the frontline indices, with Nifty Midcap 50 trading 0.56 percent higher from the previous close

Read More

​ Midcap stocks managed to outperform the frontline indices, with Nifty Midcap 50 trading 0.56 percent higher from the previous close Midcap stocks managed to outperform the frontline indices, with Nifty Midcap 50 trading 0.56 percent higher from the previous close  Moneycontrol Latest News Read More  

Midcap stocks managed to outperform the frontline indices, with Nifty Midcap 50 trading 0.56 percent higher from the previous close

Piramal Pharma up almost 4% as US FDA closes inspection at Bethlehem plant

Piramal Pharma up almost 4% as US FDA closes inspection at Bethlehem plant

The US FDA conducted a Good Manufacturing Practices (GMP) Inspection of Piramal Pharma Limited#39;s Bethlehem facility from 18th September 2023 to 27th September 2023.

Read More

​ The US FDA conducted a Good Manufacturing Practices (GMP) Inspection of Piramal Pharma Limited#39;s Bethlehem facility from 18th September 2023 to 27th September 2023. The US FDA conducted a Good Manufacturing Practices (GMP) Inspection of Piramal Pharma Limited#39;s Bethlehem facility from 18th September 2023 to 27th September 2023.  Moneycontrol Latest News Read More  

The US FDA conducted a Good Manufacturing Practices (GMP) Inspection of Piramal Pharma Limited#39;s Bethlehem facility from 18th September 2023 to 27th September 2023.

Shree Renuka Sugars slip 3% as Q2 loss widens to Rs 206 crore

Shree Renuka Sugars slip 3% as Q2 loss widens to Rs 206 crore

The current liabilities of the Shree Renuka Sugars and its subsidiaries exceed its current assets by Rs 2,452.1 crore.

Read More

​ The current liabilities of the Shree Renuka Sugars and its subsidiaries exceed its current assets by Rs 2,452.1 crore. The current liabilities of the Shree Renuka Sugars and its subsidiaries exceed its current assets by Rs 2,452.1 crore.  Moneycontrol Latest News Read More  

The current liabilities of the Shree Renuka Sugars and its subsidiaries exceed its current assets by Rs 2,452.1 crore.

Nazara Tech Q2 net profit jumps 53.3% to Rs 24.2 crore; stock rises 1%

Nazara Tech Q2 net profit jumps 53.3% to Rs 24.2 crore; stock rises 1%

The Nazara Technologies stock has given a return of 42.68 percent over the last six months. The benchmark Nifty50 index has given a return of 6.45 percent over the same duration.

Read More

​ The Nazara Technologies stock has given a return of 42.68 percent over the last six months. The benchmark Nifty50 index has given a return of 6.45 percent over the same duration. The Nazara Technologies stock has given a return of 42.68 percent over the last six months. The benchmark Nifty50 index has given a return of 6.45 percent over the same duration.  Moneycontrol Latest News Read More  

The Nazara Technologies stock has given a return of 42.68 percent over the last six months. The benchmark Nifty50 index has given a return of 6.45 percent over the same duration.

en_USEnglish
hi_INहिन्दी en_USEnglish